NIH-funded research R01 grant

How calcium signaling affects lymphatic muscle cell function

Official title: Regulation of lymphatic muscle cell function by store operated calcium entry signaling

Funded at University of Missouri-Columbia · NIH-10942329 · Data updated 2026-11-12

This study is looking at how calcium signals in lymphatic muscle cells help control fluid movement in the body, especially for people with secondary lymphedema, a condition that causes painful swelling, to find new ways to improve their lymphatic function.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startAugust 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$587,042
NIH project number1R01HL175083-01
Project IDNIH-10942329 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with secondary lymphedema, particularly those experiencing significant swelling and related complications.

Less likely to help

Patients with primary lymphedema or those without any lymphatic dysfunction may not benefit from this research.

What this research studies

This research investigates the role of calcium signaling in lymphatic muscle cells, which are crucial for fluid transport in the body. It focuses on understanding how these cells regulate their function in response to pressure changes, particularly in patients with secondary lymphedema, a condition that causes debilitating swelling. The study will explore the mechanisms behind calcium dynamics and how they influence the contractile activity of lymphatic muscle cells. By identifying these processes, the research aims to uncover potential therapeutic targets for improving lymphatic function.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for patients suffering from secondary lymphedema, potentially alleviating their symptoms and improving their quality of life.

How similar studies have gone: While the specific mechanisms of calcium signaling in lymphatic muscle cells are less explored, similar approaches in other areas of signal transduction have shown promise in improving treatment outcomes.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Zawieja, Scott D. — University of Missouri-Columbia
  • Study coordinator: Zawieja, Scott D.

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.